Details
Stereochemistry | EPIMERIC |
Molecular Formula | C20H24O10 |
Molecular Weight | 424.3986 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 6 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@@H](OC2=CC=CC=C2COC(=O)C3(O)C=CCCC3=O)[C@H](O)[C@@H](O)[C@@H]1O
InChI
InChIKey=CZDNLUMNELLDDD-QZFWYPLZSA-N
InChI=1S/C20H24O10/c21-9-13-15(23)16(24)17(25)18(30-13)29-12-6-2-1-5-11(12)10-28-19(26)20(27)8-4-3-7-14(20)22/h1-2,4-6,8,13,15-18,21,23-25,27H,3,7,9-10H2/t13-,15-,16+,17-,18-,20?/m1/s1
Molecular Formula | C20H24O10 |
Molecular Weight | 424.3986 |
Charge | 0 |
Count |
|
Stereochemistry | EPIMERIC |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 6 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/26740180Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24286322
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26740180
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/24286322
Salicortin, a phenolic glycoside, is the dominant secondary metabolites in many plants, including Populus and Salix species, and exerts various biological effects, such as anti-amnesic and anti-adipogenic effects. It was reported that salicortin significantly inhibited iNOS expression and NO production in LPS-stimulated macrophages and microglia. Salicortin suppressed TNF-α-induced ICAM-1 expression in human endothelial cells. These studies suggest that salicortin has immune-modulatory activity, even though the molecular action mechanism for this activity has not been fully determined. Recently also was dfiscovered that salicortin may be of interest in developments of treatment for osteoclast related diseases by down-regulating JNK and NF-κB/NFATc1 signaling pathways.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: map04064 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26740180 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24286322
Effects of salicortin on LPS-induced iNOS expression and NO production in RAW 264.7 macrophages was studied. Cells were pretreated with the indicated concentrations of salicortin (10-40 ug/mL) for 3 h and were then stimulated with LPS (1 μg/ml) for 18 h (for protein) or 4 h (for mRNA). Cell lysates were electrophoresed and the protein expression of iNOS was detected by the specific antibody. Salicortin-mediated inhibition of NO production in LPS-stimulated RAW 264.7 cells is associated with the inhibition of iNOS expression at a transcriptional level.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:37:41 GMT 2023
by
admin
on
Sat Dec 16 09:37:41 GMT 2023
|
Record UNII |
YI29948E0Q
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
YI29948E0Q
Created by
admin on Sat Dec 16 09:37:41 GMT 2023 , Edited by admin on Sat Dec 16 09:37:41 GMT 2023
|
PRIMARY | |||
|
11016-74-3
Created by
admin on Sat Dec 16 09:37:41 GMT 2023 , Edited by admin on Sat Dec 16 09:37:41 GMT 2023
|
SUPERSEDED | |||
|
DTXSID70952264
Created by
admin on Sat Dec 16 09:37:41 GMT 2023 , Edited by admin on Sat Dec 16 09:37:41 GMT 2023
|
PRIMARY | |||
|
29836-41-7
Created by
admin on Sat Dec 16 09:37:41 GMT 2023 , Edited by admin on Sat Dec 16 09:37:41 GMT 2023
|
PRIMARY | |||
|
115158
Created by
admin on Sat Dec 16 09:37:41 GMT 2023 , Edited by admin on Sat Dec 16 09:37:41 GMT 2023
|
PRIMARY |